1. Liu L, Xu Q, Cheng L, Ma C, Xiao L, Xu D, Gao Y, Wang J, Song H. NPY1R is a novel peripheral blood marker predictive of metastasis and prognosis in breast cancer patients. Oncol Lett. 2015 Feb;9(2):891-896. doi: 10.3892/ol.2014.2721. Epub 2014 Nov 20. PMID: 25624911; PMCID: PMC4301529.
2. Wang L, Rao F, Zhang K, Mahata M, Rodriguez-Flores JL, Fung MM, Waalen J, Cockburn MG, Hamilton BA, Mahata SK, O'Connor DT. Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. J Am Coll Cardiol. 2009 Sep 1;54(10):944-54. doi: 10.1016/j.jacc.2009.05.035. Erratum in: J Am Coll Cardiol. 2009 Oct 6;54(15):1482. PMID: 19712806; PMCID: PMC2792636.
3. Ouedraogo M, Lecat S, Rochdi MD, Hachet-Haas M, Matthes H, Gicquiaux H, Verrier S, Gaire M, Glasser N, Mély Y, Takeda K, Bouvier M, Galzi JL, Bucher B. Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization. Traffic. 2008 Mar;9(3):305-24. doi: 10.1111/j.1600-0854.2007.00691.x. Epub 2007 Dec 14. PMID: 18088318.
4. Park, C., Kim, J., Ko, SB. et al. Structural basis of neuropeptide Y signaling through Y1 receptor. Nat Commun 13, 853 (2022).